Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Xgeva (denosumab) - Important Safety Information from Amgen as approved by the HPRA (May 2018)
Notice type:
3rd Party Publications
Date:
17/05/2018
Problem Or Issue:
Important Safety Information communication from Amgen on the risk of new primary malignancy with Xgeva (denosumab)
Important Safety Information - Xgeva (denosumab)
« Back
Date Printed: 26/04/2024